In brief: Multiple Sclerosis Society
The Multiple Sclerosis Society has condemned as 'breathtaking bungling' the announcement by the National Institute for Clinical Excellence that no decision on the drugs beta interferon and glatiramer acetate will be made before July 2001. NICE said new evidence had come to light which needed to be taken into account.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here